Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

Viking Therapeutics (VKTX) is identified by Oppenheimer among five potential biotech M&A candidates ahead of J.P. Morgan Healthcare Conference. Read more here.

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focusing on developing innovative immunotherapies for patients with cancer and other incurable diseases, has announced positive data from its ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

President Donald Trump talks to the media at a public press event following the RNC debate in Houston, Texas in February 2016. Picture: Stock_photo_world/Shutterstock ...

Arcellx, Inc. (NASDAQ:ACLX – Get Free Report)’s share price rose 5.1% on Wednesday after UBS Group raised their price target on the stock from $106.00 to $114.00. UBS Group currently has a buy ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Below is Validea's guru fundamental report for ARCELLX INC (ACLX). Of the 22 guru strategies we follow, ACLX rates highest using our P/B Growth Investor model based on the published strategy of ...

Buy ACLX near 82.72 target 98.67 stop loss @ 82.48 Details The technical summary data tells us to buy ACLX near 82.72 with an upside target of 98.67. This data also tells us to set a stop loss @ 82.48 ...

In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Arcellx Inc (ACLX – Research Report). The company’s shares closed yesterday at $82.27. Pick the ...

Arcellx (NASDAQ:ACLX – Get Free Report)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a research note issued to investors on Monday,Benzinga reports.